Importantly, parallel measurements of CRP and interleukin 6 (Il-6) turned out to be insufficient to establish inflammation, as concluded from large-scale epidemiological studies and meta-analyses of mortality outcomes due to a variety of causes, including cancer, cardiovascular disease, and metabolic syndrome (e.g., [52,53,54]). The gene discussed is IL6; the disease is cancer.